Presentation is loading. Please wait.

Presentation is loading. Please wait.

End Stage Renal Disease Interstitial Nephritis

Similar presentations


Presentation on theme: "End Stage Renal Disease Interstitial Nephritis"— Presentation transcript:

1 End Stage Renal Disease Interstitial Nephritis
Major Case Study Krista Blackwell Sodexo Mid-Atlantic DI January 28, 2014

2 Objectives Define Interstitial Nephritis
Identify etiology and pathophysiology of Interstitial Nephritis Discuss treatment and Medical Nutrition Therapy for patients with ESRD

3 Functions of the Kidney
Elimination of waste products BP regulation Volume and fluid maintenance Electrolyte balance Acid-base balance Ca-phos homeostasis

4 Interstitial Nephritis
Inflammation of the spaces between the kidney tubules Acute or chronic Etiology Drug induced: Antibiotics, NSAIDS Autoimmune diseases and Systemic Diseases Kawasaki’s Disease Sjogren syndrome Systemic Lupus Erythematosus Infections: Bacteria, Viruses (HIV) Idiopathic Chronic: Sickle cell disease, DM, vesicoureteral reflux

5 Interstitial Nephritis
Pathophysiology Not completely known Depends on the original cause of the disease Immune response Inflammatory response Infiltrates: lymphocytes, macrophages, eosinophils, plasma cells Decrease in renal function ESRD and Dialysis

6 Medical Management Acute Interstitial Nephritis
Removal of drug causing condition Steroids Cyclophosphamide and cyclosporine Chronic Interstitial Nephritis ESRD: GFR <15 mL/min Immunosuppressive therapy Kidney transplant Dialysis Phosphate binders Calcium Supplements Epogen: Manage anemia MVI: B complex, Vit C Do not need: Vit A, inactive Vit D

7 MNT in ESRD Goal: Control edema and electrolyte imbalances
Sodium: 2000 mg/day Potassium: mg/day Phosphorus: mg/day Protein: g/kg/day in HD GFR <50 without dialysis: g/kg/day Fluid management With HD: ~750ml + urine output

8 Nutrition in HIV and AIDS
CD4 count <200 mm3= AIDS Change in body composition Loss of LBM and body cell mass Vit B12 deficiency Wasting Malabsorption Increased metabolic rate: Catabolic state Lipoatrophy Opportunistic Infections TB, pneumonia, oral candidiasis Nutrition Recommendations: HIV Kcal: kcal/kg IBW Protein: g/kg actual weight AIDS Kcal: kcal/kg actual weight Protein: g/kg actual weight MVI with minerals

9 Case Study: Admission JB is a 41 year-old African American male
Presented to the ED at SGAH on December 10th, with intractable nausea and vomiting Decreased urine output JB was admitted to SGAH for monitoring, evaluation, and treatment of renal failure

10 Medical Diagnoses Acute renal failure on chronic kidney disease Anemia
Hypocalcemia Hyponatremia

11 Past Medical History Hypertension: Non compliant with medications
HIV diagnosed in 1996 CKD: Untreated

12 Past Medical History: Johns Hopkins
February 19, 2008: “HIV 101” March 4, 2008: Follow-up May 10, 2012: Scheduled kidney biopsy June 4, 2012: Kidney biopsy, Cr 3.4 October 22, 2012: Follow up with primary care physician. BP 160/110, Cr 3.75 April 16, 2013: Noncompliant with medications. Wt: 72.4 kg May 30, 2013: CD4 743, Cr 6.0 Nov. 6, 2013: Moore Clinic

13 Social History Adopted English speaking, Christian
Non-smoker, no history of smoking No alcohol or drug use Employment: JB works full-time at the housing authority doing office work Lives alone in a single level home in Gaithersburg Single, no children Education level unknown, able to read and write

14 Hospital Course and Consultations
Dec. 10: Admission Dec. 11: Infectious Disease Dec. 12: Retroperitoneal ultrasound, chest x-ray, hemodialysis catheter placement Dec. 11, 13, 14, 17, 20: Nutrition Dec. 13, 14, 16, 17, 20: Case Management Dec. 13: OT & PT Dec. 17: Guided renal biopsy: Dx. Interstitial Nephritis Dec. 12, 13, 16, 18, 20: HD Dec. 20: Discharge

15 Hospital Medications

16 Medications

17 Anthropometric Data Ht: 177 cm, 69.69” Wt: BMI: 19.79
12/10: 62 kg, lb 12/17: 63.4 kg, lb BMI: 19.79 IBW: 75.5 kg, 166 lb %IBW: 83% Usual Body Weight: 74.1 kg, 163 lb % Wt change: 16.32% wt loss over 2-3 months

18 Initial Nutrition Assessment: Dec. 11th
Risk level: High Diet: NPO for HD catheter placement Summary: JB reported a lb wt loss over the past 2-3 months. Has not vomited in 2 days. Does not want HD. HD order in chart.

19 Laboratory Data

20 Nutrition Prescription
Mifflin-St Jeor: REE= 1529 (1.1)(1.4)= 2355 kcal 38 kcal/kg Protein: gm ( g/kg) Without HD g/kg Fluid: 1860 ml ( ml + urine output)

21 Nutrition Diagnoses Diagnoses I: Malnutrition (severe) R/T HIV and renal failure AEB >7.5% wt loss in 3 months and <75% intake for >1 month Diagnoses II: Altered nutrition-related laboratory values R/T renal failure AEB elevated BUN, Cr, and phos.

22 Nutrition Intervention
Goals: Pt to meet >75% of estimated needs within 3-4 days. Pt to maintain wt throughout LOS Recommend Nepro BID Will monitor need for renal diet education

23 Monitoring and Evaluation
Monitor food and beverage intake Monitor biochemical data: BUN, Creatinine, electrolytes, and triglycerides Monitor weights

24 Nutrition Reassessment: Dec. 13th
Risk Level: High Diet: Renal Dialysis Summary: Pt extremely lethargic, minimal responses, vomited this morning. Pt had HD cath. placed and received HD yesterday, Dec.12th. Pt still has poor po intake. Consumed 0% of breakfast.

25 Laboratory Data: Dec. 13th

26 Nutrition Prescription
Mifflin-St Jeor: REE= 1529 (1.1)(1.4)= 2355 kcal 38 kcal/kg Protein: g g/kg Fluid: 1860 mL

27 Nutrition Diagnoses Diagnoses I: Malnutrition R/T HIV and renal failure AEB >7.5% wt loss in 3 months and <75% intake for >1 month Diagnoses II: Altered nutrition-related laboratory values R/T renal failure AEB elevated BUN, Cr, and phos.

28 Nutrition Reassessment: Dec. 13th
Interventions: Goals: Pt to meet >75% of estimated needs within 3-4 days: Not met, continue goal Pt to maintain wt throughout LOS: Progress towards goal Rec. increasing Nepro to TID. Monitoring and Evaluation: Monitor food and beverage intake Monitor biochemical data: BUN, Creatinine, electrolytes, triglycerides Monitor weights Will monitor need for renal diet education

29 Nutrition Education: Dec. 14th
RD: AN Pt has been drinking Nepro, but not eating very much. Pt dislikes hospital food Provided renal diet education and printed materials from NCM Provided “All Time Favorites” list and reviewed Renal diet options

30 Nutrition Reassessment: Dec. 17th
Risk Level: High Diet: NPO for kidney biopsy Summary: N/V improved, pt still has fair po intake because he dislikes food provided, consumed about 50% of meals yesterday Diagnoses I: Malnutrition R/T HIV and renal failure AEB >7.5% wt loss in 3 months and <75% intake for >1 month Diagnoses II: Altered nutrition-related laboratory values R/T renal failure AEB elevated BUN, Cr, and phos.

31 Laboratory Data

32 Nutrition Reassessment: Dec. 17th
Interventions: Goals: Pt to meet >75% of estimated needs within 3-4 days: Not met, progress towards goal Pt to maintain wt throughout LOS: Progress towards goal Pt’s renal labs WNL since starting dialysis Recommend changing current diet to 2 gm Na restriction to increase po intake Monitoring and Evaluation: Monitor pt’s po intake Monitor renal labs: BUN, Cr, K, phos, Na Monitor triglycerides Monitor weight trends. Requested RN to take wt on pt today since no new weights have been obtained since pt was admitted

33 Nutrition Reassessment: Dec. 20th
Risk Level: Moderate Diet: Low Sodium: 2 gm Summary: Nephrologist stated that he is not concerned with JB’s K levels, but that JB needs further phosphorus diet education. Pt denied N/V, able to consume regular diet and drinking Nepro. Pt to be d/c today with dialysis 3x per week Education: Nephrologist requested pt receive low phosphorus diet Ed. Provided pt with verbal explanation and written material from NCM Pt verbalized understanding of information provided. Estimated compliance: High.

34 Laboratory Data

35 Laboratory Data

36 Nutrition Diagnoses Diagnoses I: Malnutrition R/T HIV and renal failure AEB >7.5% wt loss in 3 months and <75% intake for >1 month Diagnoses II: Altered nutrition-related laboratory values R/T renal failure AEB elevated BUN, Cr, and phos.

37 Nutrition Reassessment: Dec. 20th
Interventions: Goals: Pt to meet >75% of estimated needs within 3-4 days: Met Pt to maintain wt throughout LOS: Met Pt’s renal labs WNL since starting dialysis: Met Recommend continuing 2 gm Na restriction diet. Low phosphorus. Monitoring and Evaluation: Monitor pt’s po intake Monitor renal labs: BUN, Cr, K, phos, Na Monitor triglycerides Monitor weight trends

38 Discharge Summary: Friday Dec. 20th
Discharge Diagnoses: Chronic Kidney Disease-dialysis initiated Anemia secondary to chronic kidney disease Hypertension Interstitial nephritis on kidney biopsy: f/u at Johns Hopkins Hospital AIDS on antiretroviral medications. Discharge medications: Calcitriol, PhosLo, Darunavir, Intelence, Ferrous Sulfate, Lisinopril, Metoprolol, Raltegravir, and Norvir Scheduled for HD at Middletown DaVita M,W,F

39 References Moore, Linda W. Implications for Nutrition Practice in the Mineral-Bone Disorder of Chronic Kidney Disease. American Society for Parenteral and Enteral Nutrition. Nutrition in Clinical Practice. Vol. 26 Num. 4. Aug Width, Mary; Reinhard, Tonia. The Clinical Dietitian’s Essential Pocket Guide. Lippincott Williams & Wilkins Crowe, J., Pronsky, Z. Food Medication Interactions. 17th ed. Food-Medication Interactions DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res Jan;39(Database issue):D 
PMID: MedlinePlus. Interstitial Nephritis. U.S. National Library of Medicine NIH. September Web URL: Praga, Manuel., Gonzalez, Ester. Acute Interstitial Nephritis. International Society of Nephrology. March 2010. Wyatt, Christina M., Morgello, Susan., Katz-Malamed, Rebecca., Wei, Catherine., Klotman, Mary E., Klotman, Paul E., D’Agati, Vivette D. The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. Kidney International Boyd, Joanna K., Cheung, Chee K., Molyneux, Karen., Feehally, John., Barratt., Jonathan. An update on the pathogenesis and treatment of IgA nephrology. International Society of Nephrology. February 2012. National Institute of Health. Chronic Kidney Disease (CKD) and Diet: Assessment, Management, and Treatment. Treating CKD Patients who are not on dialysis. National Kidney Disease Education Program. September Web URL: Academy of Nutrition and Dietetics. Evidence Analysis Library. Chronic Kidney Disease (CKD) Protein Intake British Dietetic Association. Renal Nutrition Group. Evidence Based Dietetic Guidelines Protein Requirements of Adults on Haemodialysis and Peritoneal Dialysis, BDA Renal Nutrition Group. June 2011. Wright, Mark., Jones, Colin. Clinical Practice Guidelines. Nutrition in CKD. 5th ed. UK Renal Association NKF K/ KDOQI Guidelines. Recommendations for Clinical Performance Measures. National Kidney Foundation. New York, NY Web URL: Huang, Yuli., Cai, Xiaoyan., Zhang, Jianyu., Mai, Weiyi., Wang, Sheng., Hu, Yunzhao., Ren, Hao., Xu, Dingi. Prehypertension and Incidence of ESRD: A systematic Review and Meta-analysis. American Journal of Kidney Diseases. National Kidney Foundation. September 2013. Mahan, K.., Escott-Stump, S, Raymond, J. Krause’s Food and the Nutrition Care Process. 3rd ed. Elsevier Saunders. 2012

40 Thank You! Questions?


Download ppt "End Stage Renal Disease Interstitial Nephritis"

Similar presentations


Ads by Google